PMC:7161517 / 13148-13405 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T75","span":{"begin":101,"end":108},"obj":"Body_part"},{"id":"T76","span":{"begin":170,"end":198},"obj":"Body_part"},{"id":"T77","span":{"begin":193,"end":198},"obj":"Body_part"}],"attributes":[{"id":"A75","pred":"fma_id","subj":"T75","obj":"http://purl.org/sig/ont/fma/fma82774"},{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma284560"},{"id":"A77","pred":"fma_id","subj":"T77","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T127","span":{"begin":86,"end":87},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T128","span":{"begin":179,"end":198},"obj":"http://purl.obolibrary.org/obo/CL_0000192"},{"id":"T129","span":{"begin":219,"end":228},"obj":"http://purl.obolibrary.org/obo/SO_0000418"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T171","span":{"begin":24,"end":26},"obj":"Chemical"},{"id":"T172","span":{"begin":37,"end":48},"obj":"Chemical"},{"id":"T174","span":{"begin":88,"end":131},"obj":"Chemical"},{"id":"T176","span":{"begin":88,"end":100},"obj":"Chemical"},{"id":"T177","span":{"begin":101,"end":108},"obj":"Chemical"},{"id":"T178","span":{"begin":109,"end":121},"obj":"Chemical"},{"id":"T179","span":{"begin":122,"end":131},"obj":"Chemical"},{"id":"T183","span":{"begin":216,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A171","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A172","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_27584"},{"id":"A173","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_30834"},{"id":"A174","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_18009"},{"id":"A175","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_25523"},{"id":"A176","pred":"chebi_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/CHEBI_17154"},{"id":"A177","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_16708"},{"id":"A178","pred":"chebi_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/CHEBI_47885"},{"id":"A179","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_18367"},{"id":"A180","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_26020"},{"id":"A181","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_35780"},{"id":"A182","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_43474"},{"id":"A183","pred":"chebi_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T50","span":{"begin":7,"end":16},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T51","span":{"begin":64,"end":77},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T52","span":{"begin":219,"end":228},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T506","span":{"begin":20,"end":26},"obj":"PR:000036009"},{"id":"T507","span":{"begin":37,"end":48},"obj":"CHEBI:27584;CHEBI:27584"},{"id":"T508","span":{"begin":59,"end":63},"obj":"G_3;PG_10;PR:000003622"},{"id":"T509","span":{"begin":88,"end":100},"obj":"CHEBI:17154;CHEBI:17154"},{"id":"T510","span":{"begin":122,"end":131},"obj":"CHEBI:18367;CHEBI:18367"},{"id":"T511","span":{"begin":170,"end":178},"obj":"CL:0000359"},{"id":"T512","span":{"begin":179,"end":192},"obj":"CL:0000359;UBERON:0004237"},{"id":"T513","span":{"begin":193,"end":198},"obj":"CL:0000359"},{"id":"T514","span":{"begin":212,"end":218},"obj":"PR:000036009"},{"id":"T2864","span":{"begin":79,"end":83},"obj":"NCBITaxon:10114"},{"id":"T75186","span":{"begin":97,"end":107},"obj":"CHEBI:48416;CHEBI:48416"},{"id":"T41759","span":{"begin":140,"end":150},"obj":"GO:0010467"},{"id":"T99248","span":{"begin":154,"end":158},"obj":"G_3;PG_10;PR:000003622"},{"id":"T90139","span":{"begin":178,"end":182},"obj":"PR:000036013"},{"id":"T20676","span":{"begin":195,"end":210},"obj":"UBERON:0001515"},{"id":"T14808","span":{"begin":239,"end":247},"obj":"CHEBI:2904;CHEBI:2904"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}

{"project":"LitCovid-PubTator","denotations":[{"id":"567","span":{"begin":20,"end":26},"obj":"Gene"},{"id":"568","span":{"begin":59,"end":63},"obj":"Gene"},{"id":"569","span":{"begin":212,"end":218},"obj":"Gene"},{"id":"586","span":{"begin":37,"end":48},"obj":"Chemical"},{"id":"587","span":{"begin":88,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A567","pred":"tao:has_database_id","subj":"567","obj":"Gene:183"},{"id":"A568","pred":"tao:has_database_id","subj":"568","obj":"Gene:70008"},{"id":"A569","pred":"tao:has_database_id","subj":"569","obj":"Gene:183"},{"id":"A586","pred":"tao:has_database_id","subj":"586","obj":"MESH:D000450"},{"id":"A587","pred":"tao:has_database_id","subj":"587","obj":"MESH:D009243"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}

{"project":"2_test","denotations":[{"id":"32305401-16179584-55252950","span":{"begin":158,"end":160},"obj":"16179584"}],"text":"reased formation of Ang II. Overall, aldosterone decreased ACE2 transcription through a nicotinamide adenine dinucleotide phosphate oxidase−mediated pathway (42), and in vascular smooth muscle cells, potentiated Ang II signaling with increased phosphorylati"}